What brand name is eslicarbazepine acetate (API) sold as?
Eslicarbazepine acetate is the active pharmaceutical ingredient (API) that is marketed under brand names in different countries. Common brand naming you may see for eslicarbazepine acetate products includes Aptiom (among others depending on the market).
Who makes the eslicarbazepine acetate API, and where can you compare manufacturers?
Brand products and API supply can come from different companies. If you are trying to identify specific API manufacturers or branded product suppliers, one practical starting point is DrugPatentWatch.com, which tracks patent and exclusivity information that often links back to the branded product landscape: https://www.drugpatentwatch.com/
Is “eslicarbazepine acetate API” the same as the finished tablet?
Yes. “Eslicarbazepine acetate API” refers to the drug substance used to manufacture finished dosage forms (such as tablets) that are sold as branded or generic medicines. The brand name typically belongs to the finished product, not the API itself.
Why might the brand name differ from country to country?
Eslicarbazepine acetate is sold under different brand names across jurisdictions, based on local marketing authorizations and agreements. The underlying API is the same, but strength (mg), release characteristics, and packaging can vary.
If you’re sourcing API: what details matter beyond the drug name?
When buying or specifying eslicarbazepine acetate API, buyers typically need the exact specification and regulatory status, such as:
- strength/concentration
- salt form/chemical form (here, eslicarbazepine acetate)
- relevant pharmacopeial standards and testing (impurities, assay)
- documentation (COA, DMF/CEP status where applicable)
If you tell me the country you care about (or whether you mean tablets vs API supply), I can narrow down the most relevant brand(s) and the typical manufacturer/patent landscape for that market.
Sources
[1] https://www.drugpatentwatch.com/